Oncologist who stood up to US insurance companies lost workBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7356.167/a (Published 20 July 2002) Cite this as: BMJ 2002;325:167
- Wallace Sampson, editor. (firstname.lastname@example.org)
- Scientific Review of Alternative Medicine, Los Altos, CA 94022, USA
EDITOR—From early reports of the success of high dose chemotherapy and autologous bone marrow infusion some oncologists, including me, recognised that the procedure was far from proved, dangerous, and expensive.1 I was a reviewer for several insurance companies at the time and rejected all requests for payment for both primary and metastatic disease. The companies welcomed the first few opinions, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial